NovaBay Pharmaceuticals, Inc. Capex to Sales

Capex to Sales of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capex to Sales growth rates and interactive chart.


Highlights and Quick Summary

  • Capex to Sales for the quarter ending September 30, 2022 was 0.02 (a 703.85% increase compared to previous quarter)
  • Year-over-year quarterly Capex to Sales increased by 596.67%
  • Annual Capex to Sales for 2021 was 0.01 (a 138.46% increase from previous year)
  • Annual Capex to Sales for 2020 was 0.0 (a -10.34% decrease from previous year)
  • Annual Capex to Sales for 2019 was 0.0 (a -17.14% decrease from previous year)
  • Twelve month Capex to Sales ending September 30, 2022 was 0.01 (a 76.79% increase compared to previous quarter)
  • Twelve month trailing Capex to Sales increased by 59.68% year-over-year
Trailing Capex to Sales for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
0.01 0.01 0.01 0.01
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capex to Sales of NovaBay Pharmaceuticals, Inc.

Most recent Capex to Salesof NBY including historical data for past 10 years.

Interactive Chart of Capex to Sales of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Capex to Sales for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.02 0.0 0.01
2021 0.0 0.01 0.0 0.01 0.01
2020 0.01 0.0 0.0 0.0 0.0
2019 0.0 0.0 0.0 0.01 0.0
2018 0.01 0.0 0.0 0.0 0.0
2017 0.0 0.02 0.02 0.02 0.01
2016 0.02 0.01 0.01 0.01 0.01
2015 0.05 0.02 0.01 -0.04 0.02
2014 -0.03 0.23 -0.76 0.04 -0.06
2013 0.21 0.0 0.03 0.01 0.04
2012 0.08 0.01 0.0 -0.0 0.02
2011 0.0 0.01

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology